Summary & Overview
HCPCS S0122: Injection, Menotropins 75 IU
HCPCS Level II code S0122 denotes a 75 IU injection of menotropins, a gonadotropin medication used in assisted reproductive technology to stimulate ovarian follicular development. This code captures a specific medication unit for administration and billing, and it matters nationally due to the growing utilization of fertility services and the complexity of medication dosing and coverage.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of payer coverage patterns, typical sites of service for administration, and clinical context for use in fertility treatments. The publication outlines common billing considerations, relevant modifiers used in practice, and how this HCPCS Level II code fits into broader fertility treatment service lines.
The report also highlights benchmarks for unit reporting and common payer expectations where available, summarizes policy updates affecting medication reimbursement and prior authorization trends, and provides clinical context on when menotropins are used during controlled ovarian stimulation. Data limitations are noted where input information was not provided.
Billing Code Overview
HCPCS Level II code S0122 describes Injection, menotropins, 75 IU, a medication service used in assisted reproductive treatments to stimulate ovarian follicular development. The service type is a medication injection, typically administered by a clinician or under clinician supervision. The typical site of service for administration is an outpatient setting such as a fertility clinic, reproductive endocrinology office, or ambulatory infusion center.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 32-year-old woman with a history of anovulatory infertility presents to a reproductive endocrinology clinic for controlled ovarian stimulation as part of an in vitro fertilization (IVF) cycle. The clinician prescribes menotropins (human menopausal gonadotropins) to stimulate follicular development. The product identified by billing code S0122 is administered as intramuscular or subcutaneous injections, typically in an outpatient clinic or at home after instruction. Baseline evaluation includes a transvaginal ultrasound and serum estradiol and follicle-stimulating hormone levels. During the stimulation phase, dosing adjustments are documented based on follicular response; serial ultrasounds and estradiol measurements guide timing of trigger injection and oocyte retrieval. Typical workflow steps: patient education and consent, baseline testing, initiation of S0122 injections with documentation of lot number and units, follow-up monitoring visits (ultrasound and labs), trigger medication administration, oocyte retrieval procedure in an outpatient surgical suite, and post-retrieval follow-up.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier—default billing | Use when no special circumstances apply to the service. |